Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2022 08:37 ET | Source: AGC Biologics

AGC Biologics and Gore Collaborate on New Protein A-based Purification Technology and Contract Manufacturing Services for Antibody Therapies

Seattle, Dec. 12, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a collaboration with W.L....
August 03, 2021 08:00 ET | Source: InvestorBrandNetwork (IBN)

InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee

LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
May 01, 2018 08:00 ET | Source: Momenta Pharmaceuticals, Inc.

Momenta Pharmaceuticals Announces Date of First Quarter 2018 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), today announced that it will release its financial results for the first quarter ended March 31, 2018...
February 02, 2009 08:00 ET | Source: XOMA Royalty Corporation

XOMA to Present at the Biotechnology Industry Organization BIO CEO & Investor Conference on February 9, 2009

BERKELEY, Calif., Feb. 2, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
November 13, 2008 07:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Initiates Phase I Clinical Trial of CH-4051

CHARLOTTE, N.C., Nov. 13, 2008 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has begun dosing volunteers in the single ascending dose (SAD) study of its Phase I clinical...
November 11, 2008 11:01 ET | Source: Oakwood Laboratories, LLC

Oakwood Laboratories Offers Contract Manufacturing for Injectable Pharmaceutical Products

CLEVELAND, Nov. 11, 2008 (GLOBE NEWSWIRE) -- Oakwood Laboratories, LLC, an emerging specialty pharmaceutical company focused on advanced injectable drug delivery, today announced it is offering...
November 06, 2008 16:00 ET | Source: Threshold Pharmaceuticals, Inc.

Threshold Pharmaceuticals Reports Third Quarter 2008 Financial Results

REDWOOD CITY, Calif., Nov. 6, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD) today reported financial results for the third quarter ended September 30, 2008. The net loss for...
October 29, 2008 09:25 ET | Source: Nabi Biopharmaceuticals

Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study

ROCKVILLE, Md., Oct. 29, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today positive final results from its Phase 2 NicVAX(r) (Nicotine Conjugate Vaccine) schedule...
October 06, 2008 14:29 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Engages The Sage Group as Its Corporate Partnership Advisor for Ampligen to Treat Chronic Fatigue Syndrome

PHILADELPHIA, Oct. 6, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (Amex:HEB) today announced that it has engaged The Sage Group to assist Hemispherx to identify, select, negotiate, and close a...
September 15, 2008 16:35 ET | Source: XOMA Royalty Corporation

New Programs Added in Antibody Collaboration Between XOMA and Takeda

BERKELEY, Calif., Sept. 15, 2008 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today the initiation of new therapeutic...

Next Page keyboard_arrow_right